Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Breast Cancer - Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody
Cancer - Project Zero Delay Accelerates Drug's Path to Clinical Trial
Cancer Vaccines - Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer
Myelodysplastic Syndrome - Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
Pneumonia - Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
XenoPort, Inc. - XenoPort Announces Astellas' Plans to File an NDA for XP13512 in Japan
Adverse Drug Reactions - New adverse drug reactions study results from University of Toronto described
Angiogenesis - Scientists at Erasmus University target angiogenesis
Breast Cancer - New breast cancer study findings reported from C.G. Murphy and co-authors
Cancer - Research from Princess Margaret Hospital has provided new data on cancer
Clinical Trial Research - New clinical trial research data have been reported by V.E. Johnson and co-authors
Clinical Trial Research - University of Heidelberg publishes research in clinical trial research
Combination Therapy - Recent studies from Baylor College of Medicine, College of Medicine add new data to combination therapy
Digestive System Neoplasms - Study data from Massachusetts General Hospital provide new insights into digestive system neoplasms
Endometrial Cancer - Study data from Brown University provide new insights into endometrial cancer
Extrahepatic Disease - Research in the area of extrahepatic disease reported from University of Calgary
Gastric Cancer - Study data from Y. Kurokawa and colleagues update understanding of gastric cancer
Hepatitis C Virus - New hepatitis C virus study findings have been published by P. Qiu and colleagues
Life Sciences - Research results from G.D. Demetri and co-authors update knowledge of life sciences
Multiple Sclerosis - Research results from A. Tyndall and co-authors update knowledge of multiple sclerosis
Pharmacology - Data from Royal Marsden Hospital provide new insights into pharmacology
Rectal Cancer - Data on rectal cancer discussed by M.A. Elwanis and colleagues
Sarcoma - Researchers at Rockefeller University publish new data on sarcoma
Sarcoma - Studies conducted at R. Chugh et al on sarcoma recently published
Cholangio Cancer Therapy - Reports on cholangio cancer therapy findings from Ghent University, Department of Gastroenterology provide new insights
Clinical Trial Research - Research in the area of clinical trial research reported from University of Athens, Department of Clinical Therapeutics
Clinical Trial Research - Research on clinical trial research described by scientists at Keio University, Division of Hematology
Vaccines - Data from I. Nebie et al provide new insights into vaccines
ArQule, Inc. - ArQule Reports Second Quarter 2009 Financial Results
Arthritis - Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium
Arthritis - Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Biotechnology Business - InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Breast Cancer - Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
Breast Cancer - US Oncology Research Network Participates in Phase III Follow-up Study To BiPars Investigational Cancer Drug BSI-201
Cancer - Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
Cancer Vaccines - Largest lung cancer study, MAGRIT, shows collective commitment to development of tailored cancer therapy
Celgene Corporation - Clinical Data Evaluating Amrubicin® as Potential Therapy for Patients with Small Cell Lung Cancer Presented at 13th World Conference on Lung Cancer
Chronic Lymphocytic Leukemia - Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
Clinical Trial Research - OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
Clostridium - ViroPharma Announces Initiation of Non-Toxigenic Clostridium Difficile Phase 1 Program
Colon Cancer - Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Dementia - Pfizer Announces New Phase 1 Data From Two Novel Compounds for Alzheimers Disease at ICAD Annual Meeting
Diabetic Neuropathy - The Quigley Corporation Reports Second Quarter 2009 Results
Drug Development - Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
Flu Vaccines - Vaxin announces preliminary Phase 1 data for pandemic influenza vaccine candidate
Frost & Sullivan - The Best Time for EU Industries to Invest in Abatement Technologies is Now, Says Frost & Sullivan
Headache and Migraine - MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
Heart Failure - Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
HIV/AIDS - GeoVax Labs, Inc. Provides Clinical Studies Update
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides Pipeline Update
Merriman Curhan Ford Group, Inc. - Merriman Curhan Ford Acted as Co-Manager In Micromet's $80.5 Million Public Offering of Common Stock
Myeloma - Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
Myeloma - terna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
Osteoporosis - Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
Parkinson Disease - Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Pharmaceuticals - QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo IV Pain Therapy
Pharmaceuticals - Quark Pharmaceuticals to Participate in IBC's Oligonucleotide Therapeutics: From Concept to Implementation Conference
Pneumonia - Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia
ProChon Biotech, Ltd. - ProChon Biotech Selects Averion International for the BioCart™ Cartilage Regeneration System Study
Research and Markets - Post-ASCO Report - Coverage and Analysis of Highlighted Data Presented at the ASCO 2009 Annual Meeting
Therapy - Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement
Therapy - Nektar Therapeutics Reports Second Quarter 2009 Financial Results
